Aclaris Therapeutics to Participate in the Piper Sandler 36th Annual Healthcare Conference

Core Insights - Aclaris Therapeutics, Inc. is participating in the Piper Sandler 36th Annual Healthcare Conference on December 3, 2024 [1] - The company focuses on developing novel drug candidates for immunoinflammatory diseases [3] Company Overview - Aclaris Therapeutics is a clinical-stage biopharmaceutical company with a pipeline aimed at addressing unmet needs in immuno-inflammatory diseases [3] - The company utilizes a robust R&D engine to explore protein kinase regulation [3] Event Details - The fireside chat will take place at 1:00 PM ET in New York, New York [1] - A webcast of the event will be available on the company's website and archived for at least 30 days [2]